Treatment of chronic viral hepatitis in patients with renal disease.
In the last several years, numerous studies on the natural history and outcomes of viral hepatitis in dialysis and transplantation have been reported. Despite these, the management of hepatitis C virus or hepatitis B virus-related liver disease in end-stage renal disease continues to be an area of controversy. This article aims to address the current therapeutic options for patients with renal disease and chronic viral hepatitis.
Center for Liver and Kidney Diseases and Transplantation, Cedars-Sinai Medical Center, University of California-Los Angeles School of Medicine, 8635 West Third Street, Suite 590W, Los Angeles, CA 90048, USA.
Fabrizio
F
Fabrizi
Paul
P
Martin
Suphamai
S
Bunnapradist
D000998:Antiviral Agents / Q000627:therapeutic use; D003449:Cryoglobulinemia / Q000150:complications; D005921:Glomerulonephritis / Q000209:etiology; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000628:therapy; D016030:Kidney Transplantation; D006435:Renal Dialysis
D000998:Antiviral Agents